Koster, K.-L.; Messerich, N.-M.; Volken, T.; Cogliatti, S.; Lehmann, T.; Graf, L.; Holbro, A.; Benz, R.; Demmer, I.; Jochum, W.;
et al. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers 2023, 15, 4698.
https://doi.org/10.3390/cancers15194698
AMA Style
Koster K-L, Messerich N-M, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W,
et al. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers. 2023; 15(19):4698.
https://doi.org/10.3390/cancers15194698
Chicago/Turabian Style
Koster, Kira-Lee, Nora-Medea Messerich, Thomas Volken, Sergio Cogliatti, Thomas Lehmann, Lukas Graf, Andreas Holbro, Rudolf Benz, Izadora Demmer, Wolfram Jochum,
and et al. 2023. "Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study" Cancers 15, no. 19: 4698.
https://doi.org/10.3390/cancers15194698
APA Style
Koster, K.-L., Messerich, N.-M., Volken, T., Cogliatti, S., Lehmann, T., Graf, L., Holbro, A., Benz, R., Demmer, I., Jochum, W., Rao, T. N., & Silzle, T.
(2023). Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers, 15(19), 4698.
https://doi.org/10.3390/cancers15194698
